Lianhong Xu
City University of Hong Kong(HK)Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Immune Cell Function and Interaction, Chemical Synthesis and Analysis, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection(2013)290 cited
- → Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer(2010)200 cited
- → Total synthesis of (.+-.)-FR-900482(1992)108 cited
- → Transition metal catalyzed synthesis of 5-azaindoles(1998)90 cited
- → Total synthesis of (-)-tantazole B(1993)89 cited
- → NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability(2002)56 cited
- → RETRACTED: miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5(2015)49 cited